Just as a long investor really hasn't lost or made money until they sell, a short (I struggle to find the right term -gambler, counterfeiter maybe, but certainly not investor) does not truly book a position until they cover the counterfeit stock sold. They haven't netted out yet.
We shall see in the end which side truly makes money. This short manipulation, however, has forced a promising technology that could potentially help many solid tumor cancer patients to be sidelined and this company to raise capital at ridiculously low terms.
SHAME, SHAME, SHAME!